Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.52 |
| ▸ | CNR1 | P21554 | 8/20 | 0.48 |
| ▸ | GCK | P35557 | 1/20 | 0.45 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1620080 | 0.89 | CNR2 (0.54) | CNR2CNR1GCKATAD2NPC1 | |
| SCHEMBL4013140 | 0.88 | CNR2 (0.54) | CNR2CNR1GCKATAD2NPC1 | |
| SCHEMBL774988 | 0.87 | CNR2 (0.62) | CNR2CNR1NPC1SMN1; SMN2EGFR | |
| SCHEMBL4013326 | 0.86 | CNR2 (0.44) | CNR2CNR1GCKATAD2NPC1 | |
| SCHEMBL1620892 | 0.83 | CNR2 (0.58) | CNR2CNR1NPC1SMN1; SMN2EGFR | |
| SCHEMBL4010320 | 0.80 | CTPS1 (0.49) | CNR2CNR1GCKATAD2NPC1 | |
| SCHEMBL1620973 | 0.80 | ATAD2 (0.60) | CNR2GCKATAD2NPC1SMN1; SMN2 | |
| SCHEMBL10217374 | 0.80 | CNR2 (0.64) | CNR2CNR1GCKATAD2 | |
| SCHEMBL1620543 | 0.79 | CNR2 (0.56) | CNR2CNR1NPC1SMN1; SMN2EGFR | |
| SCHEMBL1620926 | 0.78 | CNR2 (0.55) | CNR2CNR1NPC1SMN1; SMN2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074084-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-01 | — | — | EP | claimed |
| WO-2008039645-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-04-03 | — | — | WO | claimed |
| EP-2074084-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008039645-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-04-03 | — | — | WO | disclosed |